Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,744.00
Bid: 4,744.00
Ask: 4,748.00
Change: -146.00 (-2.99%)
Spread: 4.00 (0.084%)
Open: 4,884.00
High: 4,884.00
Low: 4,716.00
Prev. Close: 4,890.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

23 Apr 2007 07:00

Intertek Group PLC23 April 2007 23 April 2007, 7:00am (UK), London Intertek acquires Genalysis minerals laboratories in Australia Intertek Group plc (Intertek), a leading international provider of quality andsafety services to a wide range of industries, has acquired Genalysis LaboratoryServices Pty Ltd (Genalysis), a leading provider of analytical laboratoryservices to the minerals exploration industry in Australia and overseas. Intertek has acquired Genalysis, a private Australian company, from itsowner-managers for an initial cash consideration of AUD 42.0 million (GBP 17.5million) and a further cash consideration of approximately AUD 14.0 million (GBP5.8 million), payable in March 2008 dependent on performance in 2007. The acquisition will complement Intertek's existing global minerals services andexpand its network and capacity. Intertek already provides a range of analyticalservices to the world's mineral, ore and mining industries with facilities inAustralia, Indonesia, China, Philippines, Papua New Guinea, Brazil and NorthAmerica. Wolfhart Hauser, Chief Executive Officer of Intertek, commented:"Genalysis complements Intertek's existing minerals business strategically andwill enable us to increase our international market share in minerals testing.At the same time, it will position us well to benefit from the growinginternational commodities market." "Development, rapid industrialisation and growing numbers of new consumers inemerging economies, are driving the global demand for minerals. As a result,Intertek is managing growing volumes of minerals testing and analysis work fromcustomers globally as they increase their exploration, production, and exportvolumes to meet this demand." -ends-ContactsAston Swift, IntertekTelephone: +44 (0) 20 7396 3400Aston.swift@intertek.com Richard Mountain / Susanne Walker, Financial DynamicsTelephone: +44 (0) 20 7831 3113Richard.mountain@fd.comSusanne.walker@fd.com Notes to Editors Founded in 1975 by Terry and Tena Wheeler, Genalysis offers sample preparationand analytical testing services for metals including gold, platinum, copper andnickel. Genalysis processes more than one million samples per year from over 55countries and offers fire assay, leachwell, partial digest and cyanidetechniques. With over 300 employees, it has a state-of-the-art laboratory inPerth and sample preparation facilities in Kalgoorlie and Adelaide (Australia)and Johannesburg (South Africa). Intertek supports minerals-sector clients around the world with samplepreparation and analysis of a wide range of metals, minerals, and raw materials,including gold, platinum, zinc and copper. With a variety of clients thatoperate from exploration through to production stages, Intertek also designs andoperates mining preparation plants and analytical laboratories at mine andexploration sites around the globe. About IntertekIntertek is a leading international provider of quality and safety services to awide range of global and local industries. Partnership with Intertek bringsincreased value to customers' products and processes, ultimately supportingtheir success in the global market place. Intertek has the experience,expertise, resources and global reach to support its customers through theirnetwork of more than 930 laboratories and offices, 18,000 people in 109countries around the world.For further information, visit www.intertek.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Jun 20241:00 pmRNSDirector/PDMR Shareholding
29th May 20241:00 pmRNSDirector/PDMR Shareholding
28th May 20247:00 amRNSDirectorate Change
24th May 20241:30 pmRNSResult of AGM
24th May 20247:00 amRNSTrading Statement
22nd May 20241:00 pmRNSBlock listing Interim Review
22nd Mar 20249:00 amRNSAnnual Financial Report
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
4th Mar 20247:00 amRNSAcquisition
1st Mar 20241:00 pmRNSDirectorate Change
28th Feb 20241:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSTrading Statement
22nd Nov 20231:00 pmRNSBlock listing Interim Review
14th Sep 20231:00 pmRNSDirector Declaration
24th Aug 20237:00 amRNSAcquisition
28th Jul 20237:00 amRNSHalf-year Report
12th Jul 202310:00 amRNSDirectorate Change
7th Jun 20231:00 pmRNSDirector/PDMR Shareholding
31st May 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20233:00 pmRNSHolding(s) in Company
30th May 20231:00 pmRNSBlock listing Interim Review
24th May 202311:00 amRNSResult of AGM
24th May 20237:00 amRNSTrading Statement
3rd May 20237:00 amRNSCapital Markets Event
27th Apr 20234:00 pmRNSDirector Declaration
26th Apr 20234:30 pmRNSDirector Declaration
20th Apr 20234:00 pmRNSDirector Declaration
3rd Apr 20237:00 amRNSAcquisition
24th Mar 20239:00 amRNSNotice of 2023 AGM
21st Mar 20239:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSDirectorate Change
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSFinal Results
23rd Dec 202210:00 amRNSDirectorate Change
13th Dec 202211:00 amRNSDirector Declaration
12th Dec 20221:00 pmRNSDirector Declaration
24th Nov 20227:00 amRNSTrading Statement
21st Nov 20221:00 pmRNSBlock listing Interim Review
2nd Aug 20229:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:01 amRNSAcquisition
29th Jul 20227:00 amRNSHalf-year Report
21st Jun 20221:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSDirectorate Change
25th May 202211:00 amRNSResult of AGM
25th May 20227:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.